The Early Diabetes Intervention Program--is early actually late? (Q38268577)

1 September 2017

1 reference

title

The Early Diabetes Intervention Program--is early actually late? (English)

1 reference

1 September 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Michael Bergman

series ordinal

1

1 reference

1 September 2017

1 November 2014

1 reference

Diabetes - Metabolism: Research and Reviews

1 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

654-658

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

Lifetime direct medical costs of treating type 2 diabetes and diabetic complications

9 June 2020

cites work

1 reference

Inadequacies of absolute threshold levels for diagnosing prediabetes

21 January 2018

1 reference

Are current diagnostic guidelines delaying early detection of dysglycemic states? Time for new approaches

21 January 2018

1 reference

Treating postprandial hyperglycemia does not appear to delay progression of early type 2 diabetes: the Early Diabetes Intervention Program.

21 January 2018

1 reference

Profound defects in β-cell function in screen-detected type 2 diabetes are not improved with glucose-lowering treatment in the Early Diabetes Intervention Program (EDIP).

21 January 2018

1 reference

Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial

21 January 2018

1 reference

A study of the effects of acarbose on glucose metabolism in patients predisposed to developing diabetes: the Dutch acarbose intervention study in persons with impaired glucose tolerance (DAISI).

21 January 2018

1 reference

Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention

21 January 2018

1 reference

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

Hemoglobin A1c above threshold level is associated with decreased β-cell function in overweight Latino youth.

21 January 2018

1 reference

Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes

21 January 2018

1 reference

The general use of glycated haemoglobin for the diagnosis of diabetes and other categories of glucose intolerance: still a long way to go.

21 January 2018

1 reference

Fructosamine and glycated albumin for risk stratification and prediction of incident diabetes and microvascular complications: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study

21 January 2018

1 reference

Pathophysiology of prediabetes and treatment implications for the prevention of type 2 diabetes mellitus.

21 January 2018

1 reference

Preservation of β-cell function: the key to diabetes prevention

21 January 2018

1 reference

Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?

21 January 2018

1 reference

Prediabetes: evaluation of β-cell function

21 January 2018

1 reference

Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study

21 January 2018

1 reference

Impaired fasting glucose with or without impaired glucose tolerance: progressive or parallel states of prediabetes?

21 January 2018

1 reference

The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging

21 January 2018

1 reference

Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

21 January 2018

1 reference

Longitudinal trajectories of HbA1c and fasting plasma glucose levels during the development of type 2 diabetes: the Toranomon Hospital Health Management Center Study 7 (TOPICS 7)

21 January 2018

1 reference

Normal fasting plasma glucose levels and type 2 diabetes in young men.

21 January 2018

1 reference

Declining beta-cell function relative to insulin sensitivity with increasing fasting glucose levels in the nondiabetic range in children

21 January 2018

1 reference

Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men

21 January 2018

1 reference

Glucose effectiveness in nondiabetic relatives: dysglycemia and β-cell function at 10 years.

21 January 2018

1 reference

Evidence for early defects in insulin sensitivity and secretion before the onset of glucose dysregulation in obese youths: a longitudinal study

21 January 2018

1 reference

Declining β-cell function relative to insulin sensitivity with escalating OGTT 2-h glucose concentrations in the nondiabetic through the diabetic range in overweight youth.

21 January 2018

1 reference

beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis

21 January 2018

1 reference

Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study

21 January 2018

1 reference

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

21 January 2018

1 reference

Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.

21 January 2018

1 reference

What is the best predictor of future type 2 diabetes?

21 January 2018

1 reference

Plasma glucose concentration and prediction of future risk of type 2 diabetes

21 January 2018

1 reference

1-Hour plasma glucose in obese youth

21 January 2018

1 reference

Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study.

21 January 2018

1 reference

Adiponectin trajectories before type 2 diabetes diagnosis: Whitehall II study.

21 January 2018

1 reference

A novel ADIPOQ mutation (p.M40K) impairs assembly of high-molecular-weight adiponectin and is associated with early-onset obesity and metabolic syndrome

21 January 2018

1 reference

Novel biomarkers for pre-diabetes identified by metabolomics

21 January 2018

1 reference

Targeted metabolomics finds its mark in diabetes research

21 January 2018

1 reference

Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.

21 January 2018

1 reference

The potential use of biomarkers in the prevention of Type 2 diabetes

21 January 2018

1 reference

Are glycated serum proteins ready for prime time?

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Loss of beta cell function as fasting glucose increases in the non-diabetic range

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Glycemic variability in gestational diabetes mellitus and its association with β cell function

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/DMRR.2563

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25400067%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference